Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- ChecktodayChange DetectedA site-wide banner announces NIH website updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.7.0 was added to the page, indicating an updated version of the study record. Several legacy study record update notes and related metadata were removed, reflecting an update to the page's history and organization.SummaryDifference18%

- Check56 days agoChange DetectedA new note indicates 2017 (U.S. NIH Grant/Contract) funding. The site revision was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the ClinicalTrials.gov study page. This reflects a minor update to the page version rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.